Conference abstract · 18 Jul 2016
Research articlePublished 3 Aug 2017
Rosuvastatin and contrast-induced nephropathy in elective percutaneous coronary intervention: The randomized CLEAR-CIN-PCI sub study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Statins may reduce the risk of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). However, there is no knowledge that PCI performed at the same time of statin peak concentration in the blood, may cause additional benefit in renal protection. Methods: This study sought to determine whether PCI realized within the time of rosuvastatin peak concentration was associated with reduced in-hospital CIN compared with standard clinical practice. This single-center prospective, randomized, open-label, non-blinded clinical trial evaluated stable coronary artery disease patients taking chronic statin undergoing PCI. Patients were randomized to receive a loading dose of rosuvastatin (40mg within 2 to 6 hours before angioplasty) or to standard practice (without load dose of rosuvastatin). The pre-specified primary endpoint was the occurrence of CIN defined as an increase in the serum creatinine by {greater than or equal to} 0.3 mg/dl within 24 hours after intervention. Contrast-induced nephropathy after coronary angioplasty by creatinine-kinase measure. This trial is registered with (Creatine Leak After Rosuvastatin in Percutaneous Coronary Intervention [CLEAR-PCI]; (ClinicalTrials.gov number: NCT01968577). (J. Interven Cardiol 2015;28:339-347)@2015, Wiley Periodicals, Inc. Results: Of the 544 patients in the main trial, 528 participated in the CLEAR-CIN-PCI substudy, and 493 patients (244 in the rosuvastatin group and 249 in control) were analyzed. CIN occurred in 6 patients of the 244 patients (2.5%) treated with rosuvastatin compared with 9 of the 249 patients (3.6%) in control group (risk ratio, 0.80; 95% confidence interval [CI], 0.42 to 1.50; P=0.455). Conclusion: This result does not support the initiation of rosuvastatin before elective PCI to prevent CIN in patients taking chronic statin therapy.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2018
Relationship between Preoperative Urinary Microalbumin to Creatinine Ratio Level and Contrast-induced Nephropathy after Elective Coronary Angiography/Percutaneous Coronary Intervention
Conference abstract · 11 Dec 2017
The efficacy of oral trimetazidine in preventing contrast-induced nephropathy among patients undergoing elective coronary procedures: a meta-analysis of randomized controlled trials
Research article · 2014
Selenium for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Percutaneous Interventions: A Double-Blinded Randomized Controlled Trial
Conference abstract · 16 Jul 2018
Efficacy of Nicorandil in the prevention of contrast-induced nephropathy among patients with chronic kidney disease undergoing coronary angiography: A meta-analysis of randomized controlled trials
More from this journal
The newest in Interventional Cardiology.
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Kleber Bomfim A Martins”
- BylineArticles whose byline prints “Mauricio S de Oliveira”
- BylineArticles whose byline prints “Luiz Alberto Mattos”